Researchers at Mayo Clinic in Arizona, Florida and Minnesota actively study possible causes of amyotrophic lateral sclerosis (ALS). Research includes identifying biomarkers in blood and cerebrospinal fluid that may someday help to identify and monitor loss of motor neurons in ALS and aid in monitoring response to treatment.

Research also includes identifying genes that may cause or contribute to the development of ALS. Researchers study genes that may predict people who are at high risk of ALS.

In addition, researchers study potential new treatments for people with ALS and ALS-related diseases and participate in clinical trials of potential new medications. For example, researchers study how stem cells potentially may be used to prevent cell death and tissue damage.

Read more about research in neuromuscular diseases and amyotrophic lateral sclerosis (ALS). Also read about genetic analysis of novel and known genes implicated in frontotemporal dementia and amyotrophic lateral sclerosis and research in therapy for ALS.

Read more about monitoring and treating ALS.

Mayo Clinic publications

See a list of publications by Mayo Clinic doctors on amyotrophic lateral sclerosis on PubMed, a service of the National Library of Medicine.

Research Profiles

April 09, 2014